Nodal metastasis and recurrence in papillary thyroid microcarcinoma

被引:40
作者
Pisanu, Adolfo [1 ]
Saba, Alessandra [1 ]
Podda, Mauro [1 ]
Reccia, Isabella [1 ]
Uccheddu, Alessandro [1 ]
机构
[1] Univ Cagliari, Azienda Osped Univ, Presidio Policlin Monserrato, Dept Surg,Clin Chirurg, I-09042 Monserrato, CA, Italy
关键词
Papillary thyroid microcarcinoma; PTMC; Lymph node metastasis; N1; Lymph node recurrence; Prognosis; CARCINOMA; CANCER;
D O I
10.1007/s12020-014-0350-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite the majority of papillary thyroid microcarcinoma (PTMC) patients has benign clinical courses, some PTMCs have a clinical presentation similar to conventional papillary thyroid carcinoma (PTC). The aim of this study was to identify risk factors for lymph node metastasis at presentation and prognostic parameters influencing nodal recurrence in PTMC. From January 1998 to October 2013, 556 consecutive patients had a diagnosis of differentiated thyroid carcinoma in our surgical department. A total of 219 (39.4 %) patients who had a pathological diagnosis of PTMC represented the cohort for the current study. We carried out a retrospective cohort study to compare 24 PTMC patients with lymph node metastasis at diagnosis (N1) and 195 PTMC patients without lymph node involvement (N0). The comparison between groups involved evaluation of patients and tumor characteristics. A diameter [8 mm, the presence of multifocality, and extrathyroid invasion (T3) were independent risk factors for nodal involvement at presentation. The presence of T3 was the only independent prognostic parameter influencing nodal recurrence. Prognostic factors for N1 at presentation and for recurrence are pathological parameters, thus it is not possible before surgery to detect PTMC patients who are at risk. However, we believe that a full treatment protocol should be also indicated in the case of PTMC according to risk stratification and cancer stage as for the conventional counterpart of PTC.
引用
收藏
页码:575 / 581
页数:7
相关论文
共 31 条
  • [21] Prognostic Factors Affecting Neck Lymph Node Recurrence and Distant Metastasis in Papillary Microcarcinoma of the Thyroid: Results of a Study in 445 Patients
    Mercante, Giuseppe
    Frasoldati, Andrea
    Pedroni, Corrado
    Formisano, Debora
    Renna, Luigi
    Piana, Simonetta
    Gardini, Giorgio
    Valcavi, Roberto
    Barbieri, Verter
    [J]. THYROID, 2009, 19 (07) : 707 - 716
  • [22] Papillary microcarcinoma
    Noguchi, Shiro
    Yamashita, Hiroto
    Uchino, Shinya
    Watanabe, Shin
    [J]. WORLD JOURNAL OF SURGERY, 2008, 32 (05) : 747 - 753
  • [23] Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience
    Pelizzo, MR
    Boschin, IM
    Toniato, A
    Pagetta, C
    Piotto, A
    Bernante, P
    Casara, D
    Pennelli, G
    Rubello, D
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (06) : 547 - 552
  • [24] Risk Factors for Nodal Metastasis and Recurrence Among Patients with Papillary Thyroid Microcarcinoma: Differences in Clinical Relevance Between Nonincidental and Incidental Tumors
    Pisanu, Adolfo
    Reccia, Isabella
    Nardello, Oreste
    Uccheddu, Alessandro
    [J]. WORLD JOURNAL OF SURGERY, 2009, 33 (03) : 460 - 468
  • [25] Clinical and histological characteristics of papillary thyroid microcarcinoma: Results of a retrospective study in 243 patients
    Roti, Elio
    Rossi, Roberta
    Trasforini, Giorgio
    Bertelli, Fiorenza
    Ambrosio, Maria Rosaria
    Busutti, Luciano
    Pearce, Elizabeth N.
    Braverman, Lewis E.
    degli Uberti, Ettore
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (06) : 2171 - 2178
  • [26] Papillary microcarcinoma and papillary cancer of the thyroid ≤1 cm -: Modified definition of the WHO and the therapeutic dilemma
    Schoenberger, J.
    Marienhagen, J.
    Agha, A.
    Rozeboom, S.
    Bachmeier, E.
    Schlitt, H.
    Eilles, C.
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2007, 46 (04): : 115 - +
  • [27] Can increased tumoral vascularity be a quantitative predicting factor of lymph node metastasis in papillary thyroid microcarcinoma?
    Shin, Hyun Joo
    Kim, Eun-Kyung
    Moon, Hee Jung
    Yoon, Jung Hyun
    Han, Kyung Hwa
    Kwak, Jin Young
    [J]. ENDOCRINE, 2014, 47 (01) : 273 - 282
  • [28] Symptomatic versus asymptomatic papillary thyroid microcarcinoma: A retrospective analysis of surgical outcome and prognostic factors
    Sugitani, I
    Fujimoto, Y
    [J]. ENDOCRINE JOURNAL, 1999, 46 (01) : 209 - 216
  • [29] Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Explanation and Elaboration
    Vandenbroucke, Jan P.
    von Elm, Erik
    Altman, Douglas G.
    Gotzsche, Peter C.
    Mulrow, Cynthia D.
    Pocock, Stuart J.
    Poole, Charles
    Schlesselman, James J.
    Egger, Matthias
    [J]. EPIDEMIOLOGY, 2007, 18 (06) : 805 - 835
  • [30] Lymph node metastasis from 259 papillary thyroid microcarcinomas - Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection
    Wada, N
    Duh, QY
    Sugino, K
    Iwasaki, H
    Kameyama, K
    Mimura, T
    Ito, K
    Takami, H
    Takanashi, Y
    [J]. ANNALS OF SURGERY, 2003, 237 (03) : 399 - 407